Chung Christine 4
4 · FIBROGEN INC · Filed Jun 15, 2023
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Chung Christine
SVP, CHINA OPERATIONS
Transactions
- Sale
Common Stock
2023-06-13$17.60/sh−6,250$110,000→ 242,577 total - Sale
Common Stock
2023-06-14$16.66/sh−5,250$87,465→ 237,327 total - Sale
Common Stock
2023-06-14$17.46/sh−1,000$17,460→ 236,327 total
Footnotes (4)
- [F1]Shares sold pursuant to a 10b5-1 trading plan.
- [F2]The shares were sold at prices ranging from $17.31 to $18.18. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The shares were sold at prices ranging from $16.34 to $17.32. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The shares were sold at prices ranging from $17.37 to $17.61. The reporting person will provide to the SEC, the issuer or security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.